Skip to content
drillr.ai
Sign up

MRNA

Moderna, Inc.

NASDAQ · Healthcare · Biotechnology · US

$222.76
+4.01%
Ask drillr

  • Oct 26, 2026, 20:01 UTC

    Moderna, Inc. shares fell sharply, potentially ending a rally driven by optimism about its cancer vaccine.

    Source:

  • Oct 25, 2026, 19:30 UTC

    Moderna, Inc. and Merck released detailed results from a late-stage trial showing that adding personalized intismeran to Keytruda reduced the two-year risk of melanoma recurrence by 42% compared with Keytruda alone.

    Source:

  • Oct 24, 2026, 09:30 UTC

    Moderna, Inc. shares fell sharply during the past week.

    Source:

  • Oct 23, 2026, 13:00 UTC

    Law Offices of Howard G. Smith announced that it is conducting a securities fraud investigation into whether Moderna violated federal securities laws.

    Source:

  • Oct 23, 2026, 10:45 UTC

    U.S. stock futures pointed lower while oil prices climbed above $114 a barrel and some technology stocks rebounded modestly.

    Source:

  • Oct 23, 2026, 04:51 UTC

    Merck & Co., Inc. shares slipped about 1% and were up nearly 41% for 2026.

    Source:

  • Oct 22, 2026, 19:14 UTC

    Law Offices of Frank R. Cruz announced that it is investigating potential securities fraud claims on behalf of Moderna investors.

    Source:

  • Oct 13, 2026, 21:15 UTC

    Moderna, Inc. appointed Devin Smith as chief ethics and compliance officer and head of legal.

    Source:

  • Oct 13, 2026, 11:00 UTC

    Moderna, Inc. announced that it will host a conference call and webcast on November 6, 2026, to report its third-quarter financial results and provide a corporate update.

    Source:

  • Oct 12, 2026, 16:51 UTC

    Tempus AI, Inc. expanded its strategic collaborations with Moderna, Inc., Merck & Co., Inc. and RECURSION PHARMACEUTICALS, INC. to advance its precision medicine business.

    Source:

  • Oct 12, 2026, 16:16 UTC

    Shares of Moderna, Inc., BioNTech SE and NOVAVAX INC rallied following reports of a planned U.S.-led initiative to accelerate personalized cancer vaccines and expand research funding.

    Source:

  • Oct 9, 2026, 20:45 UTC

    Updated XFG-strain COVID-19 vaccines from Moderna, Inc. and Pfizer-BioNTech were scheduled to become available through Singapore’s vaccination network from October 12.

    Source:

  • Oct 9, 2026, 14:44 UTC

    The U.S. National Institutes of Health reportedly plans to accelerate cancer-vaccine development and clinical trials through a public-private initiative expected to begin in December.

    Source:

  • Oct 7, 2026, 14:30 UTC

    The Australian government established a five-year partnership linking CSIRO and Moderna, Inc. to strengthen pandemic and biosecurity response capacity.

    Source:

  • Oct 2, 2026, 00:00 UTC

    Moderna will be added to the Nasdaq-100 Index on October 9, 2026.

    Source:

  • Sep 30, 2026, 11:16 UTC

    Moderna Chief Technical Operations and Quality Officer Jerh Collins retired from the company.

  • Sep 30, 2026, 11:03 UTC

    Moderna announced that Juan Andres will return to Moderna as Chief Operating Officer.

    Source:

  • Sep 28, 2026, 22:00 UTC

    The U.S. CDC reinstated its earlier, broader COVID-19 vaccine recommendations, including for children and younger adults, in compliance with a March 2026 court stay, even though some uses are off-label relative to FDA approvals.

    Source:

  • Sep 28, 2026, 19:30 UTC

    Moderna's mRNA-based flu vaccine mFlusiva, approved by the FDA for adults 50 and over, became available for the coming respiratory virus season.

    Source:

  • Sep 25, 2026, 03:19 UTC

    Fortune magazine released its 2026 'Change the World' list of 50 companies spanning environmental protection, health and safety, access to resources for vulnerable groups, and economic development opportunities.

    Source:

  • Sep 16, 2026, 18:30 UTC

    The US Food and Drug Administration approved Moderna's mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 and older.

    Source:

  • Sep 12, 2026, 18:45 UTC

    Bloomberg announced the initial list of confirmed speakers for the eighth Bloomberg New Economy Forum, to be held in New Delhi from October 13 to 15, 2026, under the theme "A World in Play: Defining the New Levers of Power."

    Source:

  • Sep 4, 2026, 12:30 UTC

    The UK Medicines and Healthcare products Regulatory Agency (MHRA) authorised Moderna's updated COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 XFG variant, for adults and children aged six months and above.

    Source:

  • Aug 27, 2026, 19:59 UTC

    Moderna announced that its upgraded COVID-19 vaccine is expected to be available in the coming days.

    Source:

  • Aug 27, 2026, 11:20 UTC

    Moderna announced a proposed private placement of $2.0 billion aggregate principal amount of Convertible Senior Notes due 2032, with an option for initial purchasers to buy up to an additional $300 million, to qualified institutional buyers.

    Source:

  • Aug 10, 2026, 12:45 UTC

    The U.S. Food and Drug Administration approved a new mRNA-based flu vaccine from Moderna for adults aged 50 and older.

    Source:

  • Aug 6, 2026, 02:17 UTC

    Moderna announced that its influenza vaccine MflusiVa will be available at select retailers in the coming weeks.

    Source:
Page 1Next →